Systolic pressure, diastolic pressure, or pulse pressure as a cardiovascular risk factor in renal disease

Current Hypertension Reports

Volumn 12, Issue 4, 2010, Pages 307-312

  García Donaire, José A ^a   Ruilope, Luis M ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

Blood pressure; Chronic kidney disease; Diastolic blood pressure; End stage renal disease; Hypertension; Renal failure; Renin angiotensin system; Systolic blood pressure

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ALBUMINURIA; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DRUG TARGETING; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; KIDNEY FAILURE; MORBIDITY; MORTALITY; PREVALENCE; PROTEINURIA; PULSE PRESSURE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SYSTOLIC BLOOD PRESSURE;

BLOOD PRESSURE; CARDIOVASCULAR DISEASES; DIASTOLE; HUMANS; HYPERTENSION; KIDNEY DISEASES; KIDNEY FAILURE, CHRONIC; NEPHROSCLEROSIS; PREVALENCE; RENIN-ANGIOTENSIN SYSTEM; RISK FACTORS; SYSTOLE;

EID: 77956263817     PISSN: 15226417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11906-010-0129-z     Document Type: Review

References (65)

1. JJ Snyder AJ Collins 2009 KDOQI hypertension, dyslipidemia, and diabetes care guidelines and current care patterns in the United States CKD population: National Health and Nutrition Examination Survey 1999-2004 Am J Nephrol 30 44 54 10.1159/000201014 19202328
2. G Mancia G De Backer A Dominiczak, et al. 2007 2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension J Hypertens 25 1751 1762 10.1097/HJH.0b013e3282f0580f 1:CAS:528:DC%2BD2sXpslalsb0%3D 17762635
3. B Williams 2009 The changing face of hypertension treatment: treatment strategies from the 2007 ESH/ESC Hypertension Guidelines J Hypertens 27 Suppl 3 S19 S26 10.1097/01.hjh.0000356768.24507.69 1:CAS:528:DC%2BD1MXmvF2gt7Y%3D
4. M Tonelli M Wiebe B Culleton, et al. 2006 Chronic kidney disease and mortality risk: a systematic review J Am Soc Nephrol 17 2034 2047 10.1681/ASN.2005101085 16738019
5. LM Ruilope V Lahera JL Rodicio, et al. 1994 Are renal hemodynamics a key factor in the development and maintenance of arterial hypertension in humans? Hypertension 23 3 9 1:STN:280:DyaK2c7gvFygsQ%3D%3D 8282328
6. LM Ruilope C Campo JL Rodicio 1994 Relationship between blood pressure and renal function J Hypertens Suppl 12 S55 59 1:STN:280:DyaK2M3it1elsw%3D%3D 7707157
7. P Hovind P Rossing L Tarnow, et al. 2001 Progression of diabetic nephropathy Kidney Int 59 702 709 10.1046/j.1523-1755.2001.059002702.x 1:STN:280:DC%2BD3M7ptl2qsQ%3D%3D 11168952
8. CM Fisher 1985 The ascendancy of diastolic blood pressure over systolic Lancet 11 1349 1350 10.1016/S0140-6736(85)92638-8
9. WB White 2002 Systolic versus diastolic blood pressure versus pulse pressure Curr Cardiol Rep 4 463 467 10.1007/s11886-002-0107-4 12379164
10. VL Burt P Whelton EJ Roccella, et al. 1995 Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey 1988-1991 Hypertension 25 305 313 1:STN:280: DyaK2M7otV2gsA%3D%3D 7875754
11. HR Black 1999 The paradigm has shifted, to systolic blood pressure Hypertension 34 386 387 1:STN:280:DyaK1MvitVClsQ%3D%3D 10489381
12. P Sever 1999 Abandoning diastole BMJ 318 1773 10381743
13. J Amar B Chamontin 2007 Cardiovascular risk factors, atherosclerosis and pulse pressure Adv Cardiol 44 212 222 10.1159/000096732 1:CAS:528: DC%2BD2sXjvFSgsbo%3D 17075210
14. A Benetos M Zureik J Morcet, et al. 2000 A decrease in diastolic blood pressure combined with an increase in systolic blood pressure is associated with a higher cardiovascular mortality in men J Am Coll Cardiol 35 673 680 10.1016/S0735-1097(99)00586-0 1:STN:280:DC%2BD3c7nvFaitg%3D%3D 10716470
15. JA Staessen J Gasowski JG Wang, et al. 2000 Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials Lancet 355 865 872 10.1016/S0140-6736(99)07330-4 1:STN:280: DC%2BD3c3hsVektw%3D%3D 10752701
16. WB Kannel 1999 Historic perspectives on the relative contributions of diastolic and systolic blood pressure elevation to cardiovascular risk profile Am Heart J 138 205 210 10.1016/S0002-8703(99)70311-X 1:STN:280: DyaK1Mzpsl2itw%3D%3D 10467214
17. TE Strandberg K Pitkala 2003 What is the most important component of blood pressure: systolic, diastolic or pulse pressure? Curr Opin Nephrol Hypertens 12 293 297 10.1097/00041552-200305000-00011 12698068
18. SS Franklin 1999 Ageing and hypertension: the assessment of blood pressure indices in predicting coronary heart disease J Hypertens 17 S29 S36 1:STN:280:DC%2BD3c7mvVynsg%3D%3D
19. G Schillaci M Pirro MR Mannarino, et al. 2006 Relation between renal function within the normal range and central and peripheral arterial stiffness in hypertension Hypertension 48 616 621 10.1161/01.HYP.0000240346.42873.f6 1:CAS:528:DC%2BD28XpsFOrsLk%3D 16952976
20. R Asmar 2003 Benefits of blood pressure reduction in elderly patients J Hypertens Suppl 21 S25 S30 1:CAS:528:DC%2BD3sXnvFGlsrk%3D 14513948
21. SS Franklin 2004 Systolic blood pressure: It's time to take control Am J Hypertens 17 49S 54S 10.1016/j.amjhyper.2004.08.020 15607435
22. S Laurent J Cockcroft L Van Bortel, et al. 2006 European Network for Non-Invasive Investigation of Large Arteries: Expert consensus document on arterial stiffness: methodological issues and clinical applications Eur Heart J 27 2588 2605 10.1093/eurheartj/ehl254 17000623
23. A Benetos M Safar A Rudnichi, et al. 1997 Pulse pressure: a predictor of long-term cardiovascular mortality in a French male population Hypertension 30 1410 1415 1:STN:280:DyaK1c%2FmsFyiuw%3D%3D 9403561
24. J Gasowski RH Fagard JA Staessen, et al. 2002 INDANA Project Collaborators: Pulsatile blood pressure component as predictor of mortality in hypertension: a meta-analysis of clinical trial control groups J Hypertens 20 145 151 10.1097/00004872-200201000-00021 1:CAS:528:DC%2BD38XmvFCnsrk%3D 11791038
25. B Darne X Girerd M Safar, et al. 1989 Pulsatile versus steady component of blood pressure: a cross-sectional analysis and a prospective analysis on cardiovascular mortality Hypertension 13 392 400 1:STN:280:DyaL1M7ntlagtQ%3D%3D 2522417
26. S Lewington R Clarke N Qizilbash, et al. 2002 Prospective Studies Collaboration: Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies Lancet 360 1903 1913 10.1016/S0140-6736(02)11911-8 12493255
27. CMM Lawes S Van der Horn A Rodgers 2008 Global burden of blood pressure related disease, 2001 Lancet 371 1513 1518 10.1016/S0140-6736(08)60655-8 18456100 This study assesses the extent and global distribution of the burden of BP-related disease. It concludes that low-income and middle-income countries and middle-aged, prehypertensive people cause most of the disease burden
28. S Lewington R Clarke N Qizilbash, et al. 2002 Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies Lancet 360 1903 1913 10.1016/S0140-6736(02)11911-8 12493255
29. P Sever 2009 Is systolic blood pressure all that matters? Yes BMJ 339 b2665 10.1136/bmj.b2665 19592405
30. E O'Brien 2009 Is systolic blood pressure all that matters? No BMJ 339 b2669 10.1136/bmj.b2669 19592406
31. SS Franklin M Jacobs ND Wong, et al. 2001 Predominance of isolated systolic hypertension among middle aged and elderly US hypertensives: analysis based on National Health and Nutrition Examination Survey (NHANES III) Hypertension 37 869 874 1:CAS:528:DC%2BD3MXitFegtLY%3D 11244010
32. B Williams LH Lindholm P Sever 2008 Systolic pressure is all that matters Lancet 371 2219 2222 10.1016/S0140-6736(08)60804-1 18561995 These authors review evidence supporting the hypothesis that SBP contributes more of the huge global disease burden attributable to hypertension than does DBP
33. G Mancia S Laurent E Agabiti-Rosei, et al. 2009 Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document Blood Press 18 308 347 10.3109/08037050903450468 1:CAS:528:DC%2BD1MXhsFOns73O 20001654 This is an important review of current guideline recommendations according to results of the latest trials
34. A Zanchetti G Grassi G Mancia 2009 When should antihypertensive drug treatment be initiated and to what levels should systolic blood pressure be lowered? A critical reappraisal J Hypertens 27 923 934 10.1097/HJH. 0b013e32832aa6b5 1:CAS:528:DC%2BD1MXltVahtLk%3D 19381107 This paper is a critical discussion of the most debated items included in the most recent international guidelines
35. J Stamler 1973 Epidemiology of coronary heart disease Med Clin North Am 57 5 46 1:STN:280:DyaE3s7ivVynug%3D%3D 4569832
36. MT Schram PJ Kostense RA Van Dijk, et al. 2002 Diabetes, pulse pressure and cardiovascular mortality: the Hoorn Study J Hypertens 20 1743 1751 10.1097/00004872-200209000-00017 1:CAS:528:DC%2BD38XntlOmsbY%3D 12195114
37. D Martins N Tareen D Pan K Norris 2002 The relationship between body mass index and pulse pressure in older adults with isolated systolic hypertension Am J Hypertens 15 538 543 10.1016/S0895-7061(02)02269-0 12074356
38. JL Abramson WS Weintraub V Vaccarino 2002 Association between pulse pressure and C-reactive protein among apparently healthy US adults Hypertension 39 197 202 10.1161/hy0202.104270 1:CAS:528:DC%2BD38XhsFyntLc%3D 11847183
39. ST Knudsen PL Poulsen KW Hansen, et al. 2002 Pulse pressure and diurnal blood pressure variation: association with micro- and macrovascular complications in type 2 diabetes Am J Hypertens 15 244 250 10.1016/S0895- 7061(01)02281-6 11939615
40. J Kato K Kitamura T Uemura, et al. 2002 Plasma levels of adrenomedullin and atrial and brain natriuretic peptides in the general population: their relations to age and pulse pressure Hypertens Res 25 887 892 10.1291/hypres.25.887 1:CAS:528:DC%2BD3sXhtVGjs70%3D 12484513
41. RL Antikainen P Jousilahti H Vanhanen J Tuomilehto 2000 Excess mortality associated with increased pulse pressure among middle-aged men and women is explained by high systolic blood pressure J Hypertens 18 417 423 10.1097/00004872-200018040-00010 1:STN:280:DC%2BD3c3jvFelsQ%3D%3D 10779092
42. TE Strandberg VV Salomaa HT Vanhanen, et al. 2002 Isolated diastolic hypertension, pulse pressure, and mean arterial pressure as predictors of mortality during a follow-up of up to 32 years J Hypertens 20 399 404 10.1097/00004872-200203000-00014 1:CAS:528:DC%2BD38XmvFCnt7s%3D 11875306
43. M Domanski G Mitchell M Pfeffer, et al. 2002 MRFIT Research Group: Pulse pressure and cardiovascular disease-related mortality: follow-up study of the Multiple Risk Factor Intervention Trial (MRFIT) JAMA 287 2677 2683 10.1001/jama.287.20.2677 12020303
44. VM Buckalew RL Berg SR Wang, et al. 1996 Prevalence of hypertension in 1, 795 subjects with chronic renal disease: the modification of diet in renal disease study baseline cohort. Modification of Diet in Renal Disease Study Group Am J Kidney Dis 28 811 821 10.1016/S0272-6386(96)90380-7 8957032
45. J Redon E Plancha P Swift, et al. 2010 Nocturnal blood pressure and progression to end-stage renal disease or death in nondiabetic chronic kidney disease stages 3 and 4 J Hypertens 28 602 607 10.1097/HJH.0b013e328333fe4d 1:CAS:528:DC%2BC3cXitVSqt74%3D 20150824 This interesting study assesses the role of office and ambulatory blood pressure measurements on the development of ESRD in nondiabetic CKD
46. R Agarwal MJ Anderson 2006 Prognostic importance of ambulatory blood pressure recordings in patients with chronic kidney disease Kidney Int 69 1175 1180 10.1038/sj.ki.5000247 1:STN:280:DC%2BD287nvValsQ%3D%3D 16467785
47. PG Zager J Nicolie RH Brown, et al. 1998 "U" Curve association of blood pressure and mortality in haemodialysis patients Kidney Int 54 561 569 10.1046/j.1523-1755.1998.00005.x 1:STN:280:DyaK1czlsVKrsw%3D%3D 9690224
48. R Agarwal 2009 Blood pressure components and the risk for end-stage renal disease and death in chronic kidney disease Clin J Am Soc Nephrol 4 830 837 10.2215/CJN.06201208 19339424
49. AW Haider MG Larson SS Franklin D Levy 2003 Systolic blood pressure, diastolic blood pressure, and pulse pressure as predictors of risk for congestive heart failure in the Framingham Heart Study Ann Intern Med 138 10 16 12513039
50. M Tozawa K Iseki S Oshiro, et al. 2002 Evidence for elevated pulse pressure in patients on chronic haemodialysis: A case-control study Kidney Int 62 2195 2201 10.1046/j.1523-1755.2002.00665.x 12427145
51. PS Klassen EG Lowrie DN Reddan, et al. 2002 Association between pulse pressure and mortality in patients undergoing maintenance haemodialysis JAMA 287 1548 1555 10.1001/jama.287.12.1548 11911757
52. L De Nicola R Minutolo P Chiodini, et al. 2006 Global approach to cardiovascular risk in chronic kidney disease: reality and opportunities for intervention Kidney Int 69 538 545 10.1038/sj.ki.5000085 16395261
53. G Manjunath H Tighiouart H Ibrahim, et al. 2003 Level of kidney function as a risk factor for atherosclerotic cardiovascular disease in the community J Am Coll Cardiol 41 47 55 10.1016/S0735-1097(02)02663-3 12570944
54. J Chen P Muntner LL Hamm, et al. 2004 The metabolic syndrome and chronic kidney disease in U.S. adults Ann Intern Med 140 167 174 14757614
55. J Segura C Campo LM Ruilope 2004 Effect of proteinuria and glomerular filtration rate on cardiovascular risk in essential hypertension Kidney Int 6 suppl 92 S1 S5
56. KC Abbott GL Bakris 2004 What have we learned from the current trials? Med Clin North Am 88 189 207 10.1016/S0025-7125(03)00129-9 14871059
57. RT Gansevoort PE de Jong 2009 The case for using albuminuria in staging chronic kidney disease J Am Soc Nephrol 20 465 468 10.1681/ASN.2008111212 19255126
58. HH Feringa SE Karagiannis M Chonchol, et al. 2007 Lower progression rate of end-stage renal disease in patients with peripheral arterial disease using statins or angiotensin-converting enzyme inhibitors J Am Soc Nephrol 18 1872 1879 10.1681/ASN.2006080887 1:CAS:528:DC%2BD2sXnt1Wjs7Y%3D 17475817
59. TH Jafar PC Stark CH Schmid, et al. 2003 Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis Ann Intern Med 139 244 252 1:CAS:528:DC%2BD3sXnt12kurs%3D 12965979
60. S Kjeldsen S Julius 2004 Hypertension mega-trials with cardiovascular end points: effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers Am Heart J 148 747 754 10.1016/j.ahj.2004.04.037 1:CAS:528:DC%2BD2cXpt1arsb0%3D 15523303
61. JP Casas W Chua S Loukogeorgakis, et al. 2005 Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis Lancet 366 2026 2033 10.1016/S0140-6736(05) 67814-2 1:CAS:528:DC%2BD2MXht12ku7nJ 16338452
62. SD Solomon MM Rice K Jablonski, et al. 2006 Prevention of Events with ACE inhibition (PEACE) Investigators: Renal function and effectiveness of angiotensin-converting enzyme inhibitor therapy in patients with chronic stable coronary disease in the Prevention of Events with ACE inhibition (PEACE) trial Circulation 114 26 31 10.1161/CIRCULATIONAHA.105.592733 1:CAS:528: DC%2BD28XmtFegs7s%3D 16801465
63. GL Bakris PA Sarafidis MR Weir, et al. 2010 Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial Lancet 375 1173 1181 10.1016/S0140-6736(09)62100-0 1:CAS:528:DC%2BC3cXktlGitr8%3D 20170948
64. C Wanner E Ritz 2008 Reducing lipids for CV protection in CKD patients-current evidence Kidney Int Suppl 111 S24 S28 10.1038/ki.2008.520 1:CAS:528:DC%2BD1cXhsVajt7vE 19034322
65. M Evans CM Fored R Bellocco, et al. 2009 Acetaminophen, aspirin and progression of advanced chronic kidney disease Nephrol Dial Transplant 24 1908 1918 10.1093/ndt/gfn745 1:CAS:528:DC%2BD1MXmtlOgtLs%3D 19155536